Article Text

Download PDFPDF
EP1186 Basal cell carcinoma of the vulva: a case report
  1. A Seneris and
  2. JT Luna
  1. Obstetrics and Gynecology | Gynecologic Oncology, Philippine General Hospital, Manila, Philippines


Introduction/Background Basal cell carcinoma (BCC) is a rare tumor of the vulva. It is frequently seen in skin sites exposed to sun. Vulvar basal cell accounts for <1% of all BCC and 2–5% of all vulvar carcinoma. The standard of care for treatment is surgical excision with good outcomes.

Methodology We report a case of an 83-year old Gravida 3 Para 3, widow for 20 years who presented with vulvar nodule associated with pruritus and bleeding and later underwent concurrent chemoradiation therapy with Cisplatin. Tumor persistence was noted after chemoradiation and she subsequently underwent radical vulvectomy upon documentation of persistence of tumor. Patient had no evidence of disease at 8 months of follow up.

Results To the author's knowledge, this was the only well-documented case of vulvar BCC in the Philippines that was initially managed by chemoradiation followed by radical vulvectomy.

Conclusion Vulvar BCC is a rare type of vulvar carcinoma. Awareness of its presentation in the genitalia is important as early detection is critical to allow complete surgical resection. Health care providers must maintain a high index of suspicion for such lesions in the vulva and a low threshold to biopsy any abnormality on the vulva. Wide local excision is the preferred treatment for primary tumors and local recurrences.

Disclosure Nothing to disclose

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.